507 results on '"Miwa N"'
Search Results
2. When does phrenic nerve injury recover after cryoballoon ablation? Data from Japanese multicenter registry
- Author
-
Shigeta, T, primary, Miyazaki, S, additional, Isonaga, Y, additional, Arai, H, additional, Miwa, N, additional, Inaba, O, additional, Hachiya, H, additional, Yamauchi, Y, additional, Goya, M, additional, and Sasano, T, additional
- Published
- 2023
- Full Text
- View/download PDF
3. EP.08F.06 Concurrent Chemoradiotherapy Followed by Durvalumab for Elderly Patients.
- Author
-
Yatani, A., Katsurada, N., Ishihara, T., Miwa, N., Katsurada, M., Hatakeyama, Y., Kawa, Y., Hori, S., Yoshimura, S., and Tachihara, M.
- Published
- 2024
- Full Text
- View/download PDF
4. Supplementation of equine placenta extract on corneal wound in two dogs: Case report
- Author
-
Tadashi Nakagaki, Miwa Nakari, Kentarou Tahara, and Eiichi Hirano
- Subjects
corneal wound ,dogs ,placental extract ,supplementation ,Zoology ,QL1-991 - Abstract
Background: Canine corneal disease is a common condition encountered in daily practice. If the depth of corneal damage is limited to the epithelial layer, healing is often straightforward; however, if it extends into the epithelial basement membrane or corneal parenchyma, surgical treatment is the treatment of choice. Moreover, in cases where there is underlying disease or where the owner refuses surgical treatment, treatment options are often limited to eye drop treatment, which may be inadequate. Case Description: Dogs aged 10 and 14 years were admitted to the hospital with eye injuries. Based on the examination findings, the owner believed that surgical treatment would be effective; however, this could not be performed owing to the underlying condition of the cases. Hyaluronic acid and antibiotic eye drops were administered, but there was no improvement in the eye damage. The eye-drop treatment prolonged without any improvement, and in the meantime the patients' weakness became apparent. In parallel with the eye-drop treatment, the patients were given a supplement containing equine placental extract to help restore their physical fitness. Consequently, in addition to the recovery of physical fitness, a film gradually formed over the eye damage area and injuries improved eventually. Conclusion: Based on these cases, supplementation with equine placenta extract may be an effective treatment option for ocular conditions that are difficult to treat surgically. [Open Vet J 2024; 14(6.000): 1503-1508]
- Published
- 2024
- Full Text
- View/download PDF
5. The effect of electrical muscle stimulation on intentional binding and explicit sense of agency
- Author
-
Miwa Nagai, Kazuhiro Matsui, Keita Atsuumi, Kazuhiro Taniguchi, Hiroaki Hirai, and Atsushi Nishikawa
- Subjects
Intentional binding ,Sense of agency ,Electrical muscle stimulation ,Medicine ,Biology (General) ,QH301-705.5 - Abstract
The motivating question for this study is determining whether electrical muscle stimulation (EMS)-induced movements can extend the user’s ability without reducing the sense of agency. Moreover, it is crucial to find the timing of the EMS application that is robust against individual differences and environmental changes. Previous studies have reported that the user-specific EMS-application timings, determined through explicit measures of sense of agency, would effectively shorten their reaction time in a push task while maintaining their sense of agency. However, no study has investigated EMS-application timings in relation to implicit measures of sense of agency. Intentional binding, an example of an implicit measure, refers to the phenomenon whereby the interval between an intentional action and the subsequent perceptual outcome is typically perceived to be shorter than the actual interval. By measuring this perceptual shift using a Libet clock, we have identified an EMS-application timing that accelerates the users’ push action while maintaining their sense of agency. First, to conduct the EMS-application experiment while appropriately maintaining the intentional binding effect, we designed a new push task such that a pre-action, as the base timing of the EMS-application trigger, always occurs just before the push movement. (1) We showed the difference between the action-binding effect of EMS-induced involuntary movements and voluntary push movements. Subsequently, (2) we identified the EMS application timing that significantly shifted judgments of action tasks while accelerating voluntary movements. Additionally, (3) we demonstrated that the EMS application could accelerate user pushing movement while maintaining the sense of agency at this specific application time. The proposed EMS in the novel pushing setup was found to be robustly effective against individual and environmental changes.
- Published
- 2024
- Full Text
- View/download PDF
6. Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma
- Author
-
Miwa N, Nagano T, Jimbo N, Dokuni R, Kiriu T, Mimura C, Yasuda Y, Katsurada M, Yamamoto M, Tachihara M, Tanaka Y, Kobayashi K, Itoh T, Maniwa Y, and Nishimura Y
- Subjects
spiral array ,immunohistochemistry ,lung adenocarcinoma ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,card9 - Abstract
Nanako Miwa,1 Tatsuya Nagano,1 Naoe Jimbo,2 Ryota Dokuni,1 Tatsunori Kiriu,1 Chihiro Mimura,1 Yuichiro Yasuda,1 Masahiro Katsurada,1 Masatsugu Yamamoto,1 Motoko Tachihara,1 Yugo Tanaka,3 Kazuyuki Kobayashi,1 Tomoo Itoh,2 Yoshimasa Maniwa,3 Yoshihiro Nishimura1 1Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; 2Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan; 3Division of Thoracic Surgery, Kobe University Graduate School of Medicine, Kobe, JapanCorrespondence: Tatsuya Nagano Tel +81 78 382 5660Fax +81 78 382 5661Email tnagano@med.kobe-u.ac.jpPurpose: Caspase recruitment domain-containing protein 9 (CARD9) is expressed at high levels in bone marrow cells and has a crucial role in innate immunity. Current studies indicate that CARD9 also plays a key role in tumor progression, but there are few reports on the role of CARD9 in lung cancer. The aim of this study was to clarify the role of CARD9 in lung adenocarcinoma.Patients and Methods: Lung adenocarcinoma tumor samples from 74 patients who underwent complete resection at Kobe University Hospital from January 2014 to December 2014 were analyzed by immunohistochemistry. The role of CARD9 in cancer cells was analyzed using lung cancer cell lines treated with CARD9 siRNA.Results: High expression of CARD9 was observed in 32.4% of tumors, and compared to low expression of CARD9, high expression was associated with poorer overall survival (P = 0.0365). Univariate and multivariate analyses showed that high expression of CARD9 was an independent prognostic factor. Knockdown of CARD9 in lung adenocarcinoma cells inhibited proliferation but did not increase apoptosis. In addition, CARD9 activated the NF-κB pathway in a lung adenocarcinoma cell line.Conclusion: CARD9 was shown to be an independent prognostic factor of poor outcome for lung cancer and may represent a molecular target for treatment.Keywords: CARD9, lung adenocarcinoma, spiral array, immunohistochemistry
- Published
- 2020
7. Effect of cigarette smoke exposure on anti-cancer activity of alveolar macrophage to Lewis lung carcinoma in mice: 69P
- Author
-
Takeuchi, M., Takasaki, M., Miwa, N., and Tanaka, Y.
- Published
- 2016
- Full Text
- View/download PDF
8. 1474P Outcome of nivolumab and ipilimumab-based therapy for advanced non-small cell lung cancer with low or negative PD-L1 expression
- Author
-
Fukui, T., Hori, S., Hatakeyama, Y., Kiriu, T., Matsumura, K., Miwa, N., Katsurada, M., Okuno, K., Yoshimura, S., and Tachihara, M.
- Published
- 2023
- Full Text
- View/download PDF
9. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency
- Author
-
MIWA, N., AKIBA, T., KIMATA, N., HAMAGUCHI, Y., ARAKAWA, Y., TAMURA, T., NITTA, K., and TSUCHIYA, K.
- Published
- 2010
- Full Text
- View/download PDF
10. Yersinia pseudotuberculosis infection in breeding monkeys: detection and analysis of strain diversity by PCR
- Author
-
Kageyama, T., Ogasawara, A., Fukuhara, R., Narita, Y., Miwa, N., Kamanaka, Y., Abe, M., Kumazaki, K., Maeda, N., Suzuki, J., Gotoh, S., Matsubayashi, K., Hashimoto, C., Kato, A., and Matsubayashi, N.
- Published
- 2002
11. Neuromyelitis optica spectrum disorder safely and successfully treated with satralizumab during pregnancy and breastfeeding: a case report
- Author
-
Takashi Yoshida, Osamu Watanabe, Miwa Nomura, Yusuke Yoshimoto, Yoshimitsu Maki, and Hiroshi Takashima
- Subjects
neuromyelitis optica ,IL-6 ,pregnancy ,breastfeeding ,satralizumab ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
BackgroundSatralizumab, a monoclonal antibody that recognizes interleukin-6 receptors, is known to reduce the relapse rate in neuromyelitis optica spectrum disorder (NMOSD), but its safety during pregnancy has not been established. We present the case of an NMOSD patient who safely completed pregnancy, parturition, and breastfeeding under satralizumab treatment. Importantly, satralizumab transfer to umbilical cord blood, infant serum, or breast milk was not observed.Case presentationA 37-year-old Japanese female developed anti-aquaporin 4 antibody-positive NMOSD with left optic neuritis. Despite responding to steroid and azathioprine therapy, she experienced moon face and weight gain and desired the prompt reduction of the steroid dosage. She also wanted to conceive a child with a safe and preferably early pregnancy and parturition. Because pregnancy and parturition after the onset of NMOSD elevate the risk of relapse and miscarriage, treatment with satralizumab was initiated with the patient's consent. She experienced normal parturition and continued with satralizumab, steroid, and azathioprine treatments while breastfeeding without experiencing any relapses. Concentrations of satralizumab in the umbilical cord blood, infant serum, and breast milk were below the detection sensitivity.ConclusionThese findings suggest that satralizumab may be safe and effective for the perinatal management of NMOSD, especially when there are concerns about continuing pregnancy and the risk of relapse after parturition.
- Published
- 2023
- Full Text
- View/download PDF
12. MAGNETIC IRON OXIDE PARTICLES COATED WITH CARBOXYDEXTRAN FOR PARENTERAL ADMINISTRATION AND LIVER CONTRASTING: Pre-clinical profile of SH U555A
- Author
-
Lawaczeck, R., Bauer, H., Frenzel, T., Hasegawa, M., Ito, Y., Kito, K., Miwa, N., Tsutsui, H., Vogler, H., and Weinmann, H.-J.
- Published
- 1997
13. Effects of Placing a CMS Monitor to Present Side and Rear View at the Driver-centered Position on Drivers’ Rearward Visual Behavior, Cognitive Load, and Mental Stress
- Author
-
Yuki Mekata, Tomonori Ohtsubo, Yoshiaki Matsuba, Daichi Sugawara, Meiko Matsuda, and Miwa Nakanishi
- Subjects
Motor vehicles. Aeronautics. Astronautics ,TL1-4050 - Abstract
ABSTRACT: The presentation range and position that could not be obtained using conventional side and rear mirrors can be obtained using the camera monitor system (CMS). Studies have proposed the effectiveness of a side–rear wide-view monitor that covers a wide angle from left to right. However, placing such a monitor in the same position as a conventional rear mirror creates an incongruent spatial relation problem because the driver seated on the right seat is forced to shift their gaze point to the left to perceive the right side. Thus, this study clarifies the effects of placing a side-rear wide-view monitor at the driver-centered (front of the driver) position on the drivers’ cognitive load, mental stress, and rearward visual behavior. Based on a driving simulator, the proposed side–rear wide-view monitor was set at three positions: the same position as a conventional rear mirror (vehicle-centered), in front of the driver (driver-centered), and in front of the driver and raised upward (driver-centered-up). Under the driver-centered condition, the oxygenated hemoglobin in the prefrontal cortex and the heart rate decreased and the eye movement became more frequent compared with the other conditions. By placing the side–rear wide-view monitor at the driver-centered position, the driver’s cognitive load and mental stress decreased and the rearward visual behavior was closer to that of skilled drivers. Placing the side–rear wide-view monitor at the driver-centered position shows some benefits for support of rearward recognition in perspective of the effects on cognitive load.
- Published
- 2022
- Full Text
- View/download PDF
14. The CYCLOPS Response Element in the NIN Promoter Is Important but Not Essential for Infection Thread Formation During Lotus japonicus–Rhizobia Symbiosis
- Author
-
Akira Akamatsu, Miwa Nagae, and Naoya Takeda
- Subjects
CYCLOPS ,CYC-RE ,infection thread ,NODULE INCEPTION ,rhizobial infection ,root-nodule symbiosis ,Microbiology ,QR1-502 ,Botany ,QK1-989 - Abstract
The establishment of the legume-rhizobia symbiosis, termed the root-nodule symbiosis (RNS), requires elaborate interactions at the molecular level. The host plant–derived transcription factor NODULE INCEPTION (NIN) is known to be crucial for RNS, regulating associated processes such as alteration of root hair morphology, infection thread formation, and cell division during nodulation. This emphasizes the importance of the precise spatiotemporal regulation of NIN expression for the establishment of RNS; however, the detailed role of NIN promoter sequences in this process remains unclear. The daphne mutant, a nin mutant allele containing a chromosomal translocation approximately 7 kb upstream of the start codon, does not form nodules but does form infection threads, indicating that the region within 7 kb of the NIN start codon contributes to NIN expression during infection thread formation. CYCLOPS binds to a CYCLOPS response element (CYC-RE) in the NIN promoter, and cyclops mutants are defective in infection thread formation. Here, we performed complementation analysis in nin mutants, using various truncated forms of the NIN promoter, and found that the CYC-RE is important for infection thread formation. Additionally, the CYC-RE deletion mutant, generated through CRISPR/Cas9 technology, displayed a significant reduction in infection thread formation, indicating that the CYC-RE is important for the fine-tuning of NIN expression during this process. However, the fact that infection thread formation is not completely abolished in the CYC-RE deletion mutant suggests that cis and trans factors other than CYCLOPS and the CYC-RE may cooperatively regulate NIN expression for the induction of infection thread formation. [Graphic: see text] Copyright © 2022 The Author(s). This is an open access article distributed under the CC BY-NC-ND 4.0 International license.
- Published
- 2022
- Full Text
- View/download PDF
15. Daisaikoto improves fatty liver and obesity in melanocortin-4 receptor gene-deficient mice via the activation of brown adipose tissue
- Author
-
Shinichi Morita, Akira Sakamaki, Kyutaro Koyama, Osamu Shibata, Takashi Owaki, Chiyumi Oda, Atsushi Kimura, Taiki Nakaya, Katsuya Ohbuchi, Miwa Nahata, Naoki Fujitsuka, Norihiro Sakai, Hiroyuki Abe, Kenya Kamimura, and Shuji Terai
- Subjects
Medicine ,Science - Abstract
Abstract Melanocortin 4 receptor gene-knockout (MC4R-KO) mice are known to develop obesity with a high-fat diet. Meanwhile, daisaikoto, one of Kampo medicines, is a drug that is expected to have therapeutic effects on obesity. Here, we report the efficacy of daisaikoto in MC4R-KO mice. Eight-week-old MC4R-KO male mice (n = 12) were divided into three groups as follows: the SD group, which is fed with a standard diet; the HFD group, fed a high-fat diet; and the DSK group, fed with a high-fat diet containing 10% of daisaikoto. After the four-week observation period, mice in each group were sacrificed and samples were collected. The body weights at 12 weeks were significantly higher in the HFD group than in the other groups, indicating that daisaikoto significantly reduced body weight gain and fat deposition of the liver. The metabolome analysis indicated that degradation of triglycerides and fatty acid oxidation in the liver were enhanced by daisaikoto administration. In MC4R-KO mice, the cytoplasm and uncoupling protein 1 expression of brown adipose tissue was decreased; however, it was reversed in the DSK group. In conclusion, daisaikoto has potentially improved fatty liver and obesity, making it a useful therapeutic agent for obesity and fatty liver.
- Published
- 2022
- Full Text
- View/download PDF
16. Adaptation with the to high altitude in sherpas: Association insertion/deletion polymorphism in the angiotensin-converting enzyme gene
- Author
-
Droma, Y, Hanaoka, M, Basnyat, B, Arjyal, A, Neupane, P, Pandit, A, Sharma, D, Ito, M, Miwa, N, Katsuyama, Y, Ota, M, and Kubo, K
- Abstract
Article, WILDERNESS & ENVIRONMENTAL MEDICINE. 19(1): 22-29 (2008)
- Published
- 2008
17. Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
- Author
-
Tatsuhiko Wada, Makoto Hibino, Hiromi Aono, Shunsuke Kyoda, Yosuke Iwadate, Eri Shishido, Keisuke Ikeda, Nana Kinoshita, Yasuki Matsuda, Sakiko Otani, Ryo Kameda, Kenta Matoba, Miwa Nonaka, Mika Maeda, Yuji Kumagai, Junya Ako, Masayoshi Shichiri, Katsuhiko Naoki, Masato Katagiri, Masashi Takaso, Masatsugu Iwamura, Kazuhiko Katayama, Takeshi Miyatsuka, Yasushi Orihashi, Kunihiro Yamaoka, and for the CORVETTE-01 Study Group
- Subjects
double-blind ,ivermectin ,SARS-CoV-2 proliferation ,RT-PCR test ,Japan ,Medicine (General) ,R5-920 - Abstract
BackgroundTo investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.MethodsCORVETTE-01 was a double-blind, randomized, placebo-controlled study (August 2020–October 2021) conducted in Japan. Overall, 248 patients diagnosed with COVID-19 using RT-PCR were assessed for eligibility. A single oral dose of ivermectin (200 μg/kg) or placebo was administered under fasting. The primary outcome was time to a negative COVID-19 RT-PCR test result for SARS-CoV-2 nucleic acid, assessed using stratified log-rank test and Cox regression models.ResultsOverall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). No significant difference was observed in the occurrence of negative RT-PCR tests between the groups (hazard ratio, 0.96; 95% confidence interval [CI] 0.70–1.32; p = 0.785). Median (95% CI) time to a negative RT-PCR test was 14.0 (13.0–16.0) and 14.0 (12.0–16.0) days for ivermectin and placebo, respectively; 82.1% and 84% of patients achieved negative RT-PCR tests, respectively.ConclusionIn patients with COVID-19, single-dose ivermectin was ineffective in decreasing the time to a negative RT-PCR test.Clinical Trial RegistrationClinicalTrials.gov, NCT04703205.
- Published
- 2023
- Full Text
- View/download PDF
18. A case of malignant hypertension with multi-organ injury
- Author
-
Ikuo Misumi, MD, Mikiko Fukushima, MD, Kuniyasu Wada, MD, Joji Urata, MD, Koji Sato, MD, Miwa Nagano, MD, and Kenichi Tsujita, MD
- Subjects
Malignant hypertension ,Optic disc edema ,Myocardial edema ,Cerebral infarction ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
A 33-year-old woman visited our hospital due to visual loss. Her BP was 280/150 mm Hg and pulse rate was 111 beats per minute. A urinalysis showed protein in urine, suggesting kidney injury. A transthoracic echocardiography showed left ventricular hypertrophy. A Cardiac magnetic resonance imaging suggested left ventricular endocardial edema or inflammation. Ophthalmoscopy showed optic disc edema and hard exudates in both eyes. A brain MRI showed multiple high-intensity areas at the pons and white matter of the cerebrum and cerebellum. Although the patient had malignant hypertension, she was successfully treated by medication.
- Published
- 2022
- Full Text
- View/download PDF
19. Maturity onset diabetes mellitus in a patient with maternal uniparental disomy for chromosome 14
- Author
-
Kayashima, T., Katahira, M., Harada, N., Miwa, N., Kishino, T., Nakamura, Y., Kajii, T., and Niikawa, N.
- Subjects
Human genetics -- Research ,Diabetes -- Genetic aspects ,Biological sciences - Published
- 2001
20. CPA3 at 7q32 imprinted domain is a strong candidate gene for prostate cancer aggressiveness
- Author
-
Kishino, T., Kayashima, T., Yamasaki, K., Hayashida, S., Miwa, N, and Niikawa, N.
- Subjects
Genetic disorders -- Research ,Prostate cancer -- Genetic aspects ,Human genetics -- Research ,Chromosome mapping -- Genetic aspects ,Biological sciences - Published
- 2001
21. Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice
- Author
-
Takahiro Iwasawa, Shunsuke Nojiri, Atsunori Tsuchiya, Suguru Takeuchi, Takayuki Watanabe, Masahiro Ogawa, Satoko Motegi, Takeki Sato, Masaru Kumagai, Taiki Nakaya, Katsuya Ohbuchi, Miwa Nahata, Naoki Fujitsuka, Masaaki Takamura, and Shuji Terai
- Subjects
Juzentaihoto ,Cirrhosis ,Mesenchymal stem cells ,Macrophage ,Fibrosis ,Medicine (General) ,R5-920 ,Cytology ,QH573-671 - Abstract
Background: Liver cirrhosis is an end-stage multiple liver disease. Mesenchymal stem cells (MSCs) are an attractive cell source for reducing liver damage and regressing fibrosis; additional therapies accompanying MSCs can potentially enhance their therapeutic effects. Kampo medicines exhibit anti-inflammatory and anti-oxidative effects. Here, we investigated the therapeutic effect of MSCs combined with the Kampo medicine Juzentaihoto (JTT) as a combination therapy in a carbon tetrachloride (CCl4)-induced cirrhosis mouse model. Methods: C57BL/6 mice were administered JTT (orally) and/or MSCs (one time, intravenously). The levels of liver proteins were measured in the sera. Sirius Red staining and hydroxyproline quantitation of hepatic tissues and immune cells were conducted, and their associated properties were evaluated. Liver metabolomics of liver tissues was performed. Results: JTT monotherapy attenuated liver damage and increased serum albumin level, but it did not effectively induce fibrolysis. JTT rapidly reduced liver damage, in a dose-dependent manner, after a single-dose CCl4 administration. Furthermore, JTT-MSC combination therapy attenuated liver damage, improved liver function, and regressed liver fibrosis. The combination increased the CD4+/CD8+ ratio. JTT had stronger effects on NK and regulatory T cell induction, whereas MSCs more strongly induced anti-inflammatory macrophages. The combination therapy further induced anti-inflammatory macrophages. JTT normalized lipid mediators, and tricarboxylic acid cycle- and urea cycle-related mediators effectively. Conclusions: The addition of JTT enhanced the therapeutic effects of MSCs; this combination could be a potential treatment option for cirrhosis.
- Published
- 2021
- Full Text
- View/download PDF
22. Immunotoxic effect of cigarette smoke as environmental factor on immune functions and DNA damage in alveolar macrophages
- Author
-
Takeuch, M., primary, Takasaki, M., additional, Miwa, N., additional, Hirono, Y., additional, Tanaka, Y., additional, Koike, K., additional, Ishida, N., additional, and Pinkerton, K.E., additional
- Published
- 2016
- Full Text
- View/download PDF
23. 69P Effect of cigarette smoke exposure on anti-cancer activity of alveolar macrophage to Lewis lung carcinoma in mice
- Author
-
Takeuchi, M., primary, Takasaki, M., additional, Miwa, N., additional, and Tanaka, Y., additional
- Published
- 2016
- Full Text
- View/download PDF
24. Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer
- Author
-
Qingjiang Hu, Takaaki Masuda, Kensuke Koike, Kuniaki Sato, Taro Tobo, Shotaro Kuramitsu, Akihiro Kitagawa, Atsushi Fujii, Miwa Noda, Yusuke Tsuruda, Hajime Otsu, Yosuke Kuroda, Shuhei Ito, Eiji Oki, and Koshi Mimori
- Subjects
Medicine ,Science - Abstract
Abstract Gastric cancer (GC) is one of the most lethal malignant tumors. To improve the prognosis of GC, the identification of novel driver genes as therapeutic targets is in urgent need. Here, we aimed to identify novel driver genes and clarify their roles in gastric cancer. OSBPL3 was identified as a candidate driver gene by in silico analysis of public genomic datasets. OSBPL3 expression was analyzed by RT-qPCR and immunohistochemistry in GC cells and tissues. The biological functions and mechanisms of OSBPL3 in GC were examined in vitro and in vivo using GC cells. The association between OSBPL3 expression and clinical outcome in GC patients was also evaluated. Overexpression of OSBPL3 was detected in GC cells with OSBPL3 DNA copy number gains and promoter hypomethylation. OSBPL3-knockdown reduced GC cell growth in vitro and in vivo by inhibiting cell cycle progression. Moreover, an active Ras pull-down assay and western blotting demonstrated that OSBPL3 activates the R-Ras/Akt signaling pathway in GC cells. In a clinical analysis of two GC datasets, high OSBPL3 expression was predictive of a poor prognosis. Our findings suggest that OSBPL3 is a novel driver gene stimulating the R-Ras/Akt signaling pathway and a potential therapeutic target in GC patients.
- Published
- 2021
- Full Text
- View/download PDF
25. Case report: Presumptive subcutaneous malignant peripheral nerve sheath tumor with intracranial invasion and osteolysis in the posterior fossa of a dog
- Author
-
Kyosuke Hidari, Yuya Nakamoto, Keiichi Sakurai, Yoko Sakurai, Kazumi Nibe, and Miwa Nakamoto
- Subjects
peripheral nerve sheath tumor ,extracranial tumor ,intracranial invasion ,malignant lesion ,osteolysis ,occipital region ,Veterinary medicine ,SF600-1100 - Abstract
A 13-year-old castrated male Toy Poodle presented with an acute vestibular disorder. Magnetic resonance imaging and computed tomography revealed a large oval space-occupying mass with skull destruction located from the subcutaneous tissue to the posterior fossa region. Histopathologically, the mass was a bundled growth of spindle-shaped mesenchymal tumor cells between the myofibrillar and collagen bundles. The cells were moderately irregular in size and had eosinophilic stained cytoplasm. The cells were highly atypical and had rare mitotic figures. Neoplastic cells were immunoreactive for S100, GFAP, Olig-2, SOX10 and immunonegative for NF, E-cadherin, and Claudin-1. Collective findings were presumptive with a diagnosis of malignant peripheral nerve sheath tumor.
- Published
- 2022
- Full Text
- View/download PDF
26. Patents and literature
- Author
-
Smith, J. A., Luenser, S. J., Olson, N. F., Magee, E. L., Olivieri, R., Viglia, A., Degen, L., Angelini, L., Fascetti, E., Miwa, N., Masuda, Y., Kawarabuki, S., Sai, T., Saito, T., Busby, M. G., Hartwig, D. W., Heady, R., Yagi, Y., Kouno, K., Inui, T., Marshall, J. J., Thomson, A. R., Miles, B. J., Caygill, J. C., Moore, D. J., Nakamura, K., Nankai, S., Iijima, T., Ooshima, Y., Baldeschwieler, J. D., Gamble, R. C., Mauk, M. R., Shen, T. Y., Ponpipom, M. M., Khachatourians, G. G., Zaffaroni, P., Senni, A., Formiconi, L., Blair, J. E., Davis, L. T., Cabane, B., Vergnault, J., Volesky, B., Tsezos, M., Bull, F. G., Messing, R. A., Ahnell, J. E., Chen, L. F., Gong, C. S., Tsao, G. T., Katsumata, R., Green, S., Leiser, R. S., Fedde, P. A., Ghosh, S., Henry, M. P., Klass, D. L., Uemura, Y., Arimura, H., Morise, H., Funakoshi, S., Suyama, T., Lützen, N. W., Kita, D. A., Fenton, D. M., MacLennan, D. G., Ousby, J. C., Owen, T. R., Steer, D. C., Araujo, F. J. M., Calderon, I. L., Diaz, I. L., Olmedo, C., Rebeller, M., Yout, P., Lonchamp, D., Mynatt, R. L., Berg, A., Eckmayer, Z., Maselli, J. A., Horwath, R. O., Gotou, E., Satou, K., Wu, R. J., Bahl, C. P., Narang, S. A., Hershberger, C. L., Baxter, J. D., Roberts, J. L., Seeburg, P. H., Goodman, H. M., and Tsuchida, T.
- Published
- 1982
- Full Text
- View/download PDF
27. Inhibition of tumor cell growth by protein factors derived from the developing mouse brain
- Author
-
Miwa, N. and Mizuno, S.
- Published
- 1985
- Full Text
- View/download PDF
28. Bcl-2-dependent autophagy disruption during aging impairs amino acid utilization that is restored by hochuekkito
- Author
-
Miwa Nahata, Sachiko Mogami, Hitomi Sekine, Seiichi Iizuka, Naoto Okubo, Naoki Fujitsuka, and Hiroshi Takeda
- Subjects
Geriatrics ,RC952-954.6 - Abstract
Abstract Chronic undernutrition contributes to the increase in frailty observed among elderly adults, which is a pressing issue in the sector of health care for older people worldwide. Autophagy, an intracellular recycling system, is closely associated with age-related pathologies. Therefore, decreased autophagy in aging could be involved in the disruption of energy homeostasis that occurs during undernutrition; however, the physiological mechanisms underlying this process remain unknown. Here, we showed that 70% daily food restriction (FR) induced fatal hypoglycemia in 23–26-month-old (aged) mice, which exhibited significantly lower hepatic autophagy than 9-week-old (young) mice. The liver expressions of Bcl-2, an autophagy-negative regulator, and Beclin1–Bcl-2 binding, were increased in aged mice compared with young mice. The autophagy inducer Tat-Beclin1 D11, not the mTOR inhibitor rapamycin, decreased the plasma levels of the glucogenic amino acid and restored the blood glucose levels in aged FR mice. Decreased liver gluconeogenesis, body temperature, physical activity, amino acid metabolism, and hepatic mitochondrial dynamics were observed in the aged FR mice. These changes were restored by treatment with hochuekkito that is a herbal formula containing several autophagy-activating ingredients. Our results indicate that Bcl-2 upregulation in the liver during the aging process disturbs autophagy activation, which increases the vulnerability to undernutrition. The promotion of liver autophagy may offer clinical therapeutic benefits to frail elderly patients.
- Published
- 2021
- Full Text
- View/download PDF
29. SYNERGIC CARCINOSTATIC EFFECTS OF ASCORBIC ACID AND HYPERTHERMIA ON EHRLICH ASCITES TUMOR CELL
- Author
-
Saitoh, Y, primary, Yoshimoto, T, primary, Kato, S, primary, and Miwa, N, primary
- Published
- 2015
- Full Text
- View/download PDF
30. Promotive effects of hyperthermia on the сytostatic activity to ehrlich ascites tumor cells by diverse delta-alkyllactones
- Author
-
Tanaka, H., Kageyama, K., Asada, R., Yoshimura, N., and Miwa, N.
- Subjects
Uncategorized - Abstract
To evaluate promotive effects of hyperthermia on antitumor activity of new delta-alkyllactones (DALs) of low molecular weight (184–254 Da), chemically synthesized, which are different from natural macrocyclic lactones of high molecular weight (348–439 Da), such as camptothecin and sultriecin. Methods: A suspension of Ehrlich ascites tumor (EAT) cells was mixed with a DAL in a glass tube, heated at 37 or 42 °C for 30 min in a water bath, and cultured at 37 °C for 20 or 72 h. Cell viability was measured by the mitochondrial dehydrogenase- based WST-1 assay. DALs incorporated into EAT cells was extracted and measured by gas-liquid chromatography. Results: The reduction of cell viability by DALs was markedly enhanced upon the treatment at 42 °C compared to that at 37 oC. At 37 oC, delta-hexadecalactone (DH16 : 0) and delta-tetradecalactone (DTe14 : 0) displayed cytostatic activity (at 100 µM survival level: 20.7%, 66.1%; at 50 µM — 41.2%, 82.4%, respectively). Their activity was more marked at 42 °C (at 100 µM 10.6%, 27.6%; at 50 µM 30.6, 37.5 %, ibid). The other DALs, delta-undecalactone (DU11 : 0), delta-dodecalactone (DD12 : 0), and delta-tridecanolactone (DTr13 : 0) were almost ineffective. Evaluation of survival rate in the cells treated for 30 min by DALs with the next culturing of EAT cells for 72 h resulted in the enhanced carcinostatic activity of DH16:0 and DTe14:0 even at concentrations as low as 25 µM at either 37 °C (18.5%, 78.5%, ibid) or 42 °C (5.0%, 42.0%, ibid), but the others exhibited slight activity or none. DH16 : 0 was effective at either 37 °C (36.0%) or 42 °C (23.0%) even at a lower dose of 10 µM. At the same time only the most cytostatic DH16 : 0 was incorporated into EAT cells and the rate of incorporation was more at 42 °C than at 37 °C. Conclusion: Delta-hexadecanolactone (DH16 : 0) exhibited the most cytostatic effect that was significantly enhanced by hyperthermia. It allows to consider it as a potent antitumor agent, especially in combination with hyperthermia. Цель: оценить промоторный эффект гипертермии на противоопухолевую активность новых низкомолекулярных (184–254 Да) дельта-алкиллактонов (DALs), химически синтезированных из разных макроциклических высокомолекулярных (348–439Да) лактонов естественного происхождения, таких как камптотецин и салтриецин. Методы: суспензию клеток асцитной опухоли Эрлиха (EAT) смешивали с DAL в стеклянной пробирке, нагревали до 37 °C или 42 °C в течение 30 мин на водяной бане и далее культивировали при 37 °C в течение 20 или 72 ч. Оценку жизнеспособности клеток проводили с помощью WST-1 анализа, основанного на определении митохондриальной дегидрогеназы. Инкорпорированные в EAT-клетки DALs экстрагировали, их уровень измеряли с помощью газо-жидкостной хроматографии. Результаты: DALs значительно снижали жизнеспособность клеток после предварительной обработки при 42 °C по сравнению с 37 °C. При 37 °C были эффективными дельта-гексадекалактон (DH16 : 0) и дельта-тетрадекалактон (DTe14 : 0) (при 100 μM уровень выживаемости: 20,7; 66,1%; при 50 μM — 41,2; 82,4% соответственно). Этот эффект был более выраженным при 42 °C (при 100 μM 10,6; 27,6%; при 50μM 30,6; 37,5% соответственно). Другие DALs, а именно дельта-ундекалактон (DU11 : 0), дельта-додекалактон (DD12 : 0) и дельта-тридекалактон (DTr13 : 0) были практически не эффективны. Оценка уровня выживаемости EAT-клеток, 30 мин обработанных DALs с последующим культивированием в течение 72 ч, показала повышенную канцеростатичсекую активность DH16 : 0 и DTe14 :0 даже при 25 μM концентрации, как при 37 °C (18,5; 78,5% соответсвенно), так и при 42 °C (5,0; 42,0% соответственно). Для других DALs данный эффект был незначительный либо отсутствовал. DH16 : 0 оставался эффективным как при 37 °C (36,0%), так и при 42 °C (23,0%) в 10 μM концентрации. В то же время только наиболее эффективный DAL — DH16 : 0 инкорпорировался в клетки EAT, и уровень инкорпорирования был выше при 42 °C, чем при 37 °C. Выводы: дельта-гексадеканолактон (DH16 : 0) показал наибольшую цитостатическую активность, которая значительно усиливалась в комбинации с гипертермией. Этот DAL можно рассматривать как потенциальный цитостатик, действие которого усиливается при гипертермии.
- Published
- 2008
31. A Histogram Analysis of the Pixel Grayscale (Luminous Intensity) of B-Mode Ultrasound Images of the Subcutaneous Layer Predicts the Grade of Leg Edema in Pregnant Women
- Author
-
Eri Ikuta, Masafumi Koshiyama, Yumiko Watanabe, Airi Banba, Nami Yanagisawa, Miwa Nakagawa, Ayumi Ono, Keiko Seki, Haruki Kambe, Taiki Godo, Shin-ichi Sakamoto, Yoko Hara, and Akira Nakajima
- Subjects
pixel ,grayscale ,ultrasound ,image ,leg edema ,photoshop ,Medicine - Abstract
The technique most widely used to quantitatively measure leg edema is only a pitting edema method. It has recently become possible to digitize B-mode ultrasound images and accurately quantify their brightness using an image-analysis software program. The purpose of this study was to find new indices of the grade of leg skin, to study whether or not analyses of the subcutaneous layer of leg skin on ultrasound images using image-editing software program can be used to evaluate it and to digitize it. Images of 282 subcutaneous layers of leg skin in 141 pregnant women were obtained using a B-scan portable ultrasound device. Rectangular photographs (vertical: skin thickness; horizontal: width of probe) were obtained using an image-editing program, and the luminous intensity (pixel grayscale: 0–255) and thickness of the skin were calculated using a histogram. We investigated the correlation between these parameters and the grade of pitting edema (0–3). There was a significant positive correlation between the grade of pitting edema and the average luminous intensity value, its standard deviation, and the skin thickness (ρ = 0.36, ρ = 0.22, ρ = 0.51, p < 0.0001, respectively). In particular, there was strong positive correlation between the grade of pitting edema and both the total number of pixels in a rectangle × (multiplied by) the average luminous intensity value and the total number of pixels in a rectangle × the standard deviation of the average luminous intensity value (ρ = 0.58 and ρ = 0.59, p < 0.0001, respectively). We could quantitatively evaluate the grade of leg edema by analyzing ultrasound photographs of the subcutaneous layer of the leg skin using an image-editing software program and found new indices to digitize it.
- Published
- 2023
- Full Text
- View/download PDF
32. Collagen-Derived Dipeptides and Amino Acids Have Immunomodulatory Effects in M1-Differentiated RAW264.7 Cells and PBMC
- Author
-
Takaki Tominaga, Jiapeng Huang, Shuo Wang, Miwa Noguchi, Yishan Tong, Momoko Asano-Oritani, and Katsuhiko Suzuki
- Subjects
collagen ,macrophages ,cytokines ,dipeptides ,amino acids ,glycine ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
A number of food components, such as polyphenols and phytonutrients, have immunomodulatory effects. Collagen has various bioactivities, such as antioxidative effects, the promotion of wound healing, and relieving symptoms of bone/joint disease. Collagen is digested into dipeptides and amino acids in the gastrointestinal tract and subsequently absorbed. However, the difference in immunomodulatory effects between collagen-derived dipeptides and amino acids is unknown. To investigate such differences, we incubated M1 macrophages or peripheral blood mononuclear cells (PBMC) with collagen-derived dipeptides (hydroxyproline-glycine (Hyp-Gly) and proline-hydroxyproline (Pro-Hyp)) and amino acids (proline (Pro), hydroxyproline (Hyp), and glycine (Gly)). We first investigated the dose dependency of Hyp-Gly on cytokine secretion. Hyp-Gly modulates cytokine secretion from M1 macrophages at 100 µM, but not at 10 µM and 1 µM. We then compared immunomodulatory effects between dipeptides and mixtures of amino acids on M1 macrophages and PBMC. There was, however, no difference in cytokine secretion between dipeptides and their respective amino acids. We conclude that collagen-derived dipeptides and amino acids have immunomodulatory effects on M1-differentiated RAW264.7 cells and PBMC and that there is no difference in the immunomodulatory effects between dipeptides and amino acids.
- Published
- 2023
- Full Text
- View/download PDF
33. Effects of ethyl-esterization, chain-lengths, unsaturation degrees, and hyperthermia on carcinostatic effect of omega-hydroxylated fatty acids
- Author
-
Kusumoto, K., Kageyama, K., Matsuda, T., Tomura, T.T., Munakata, H., Tanaka, H., Yazama, F., and Miwa, N.
- Subjects
Original contributions - Abstract
Aim: To evaluate promotive effect of hyperthermia on the carcinostatic activity of synthesized omega-hydroxy fatty acids (wHFAs) and their ethylesters agaist Ehrlich ascites tumor (EAT) cells. Methods: EAT cells were cultured with either wHFAs or their ethylester derivatives in a water bath at either 37 °C or 42 °C for 30 min, followed by incubation in a CO2 incubator for 20 or 72 h. Mitochondrial dehydrogenase-based WST-1 assay and trypan blue dye exclusion assay were then conducted after incubation. Morphological changes were observed by scanning electron microscopy (SEM). Results: Omega-HFA having a saturated 16-carbon straight-chain (wH16:0) was the most carcinostatic (at 37 °C – viability level: 60.0%; at 42 °C – 49.6% (WST-1)) among saturated and unsaturated wHFAs with 12, 15 or 16 carbon atoms, when administrated to EAT cells at 100 µM for 20 h. Carcinostatic activity was markedly enhanced by ethyl-esterization of saturated fatty acids, such as wH16:0 (at 37 °C – 42.3%; at 42 °C – 11.2% , ibid) and wH15:0 (at 37 °C – 74.6%; at 42 °C – 25.3% , ibid), and their unsaturated counterparts were extremely effective only in combination with hyperthermia. Prolongation of the incubation period to 72 h at the same concentration increased appreciably their carcinostatic effect (wH16:0 ethylesther: 1.3%; wH15:0 ethylesther: 8.0%). These values were also supported by dye exclusion assay. The carcinostatic activity enhanced more markedly by hyperthermia (1.2%; 2.1%, ibid). SEM shows that wH16:0 ethylester-exposed EAT cells underwent extensive injury, such as deformation of cell structure or disappearance of microvilli. Conclusions: wH16:0 ethylester possesses high carcinostatic activity in vitro in combination with hyperthermia and may be utilized as potent anticancer therapeutic agent. Цель: проанализировать усиливающий эффект гипертермии на канцеростатическую активность синтезированных омегагидроксилированных жирных кислот (HFAs) и их этиловых эфиров по отноению к клеткам асцитной опухоли рлиха (EAT). Методы: клетки EAT инкубировали с HFAs или их этилэфирными производными на водной ане при 37 ° или 42 ° в течение 30 мин с дальнейим культивированием в 2 инкубаторе на протяжении 20 или 72 ч, после чего анализировали жизнеспособность клеток методами анализа WST-1, основанного на активности митохондриальных дегидрогеназ, и по включению трипанового синего. Морфологические изменения клеток определяли с использованием сканирующей электронной микроскопии. Результаты: при культивации клеток EAT в присутствии 100 M соединений в течение 20 ч омега-HFA с насыщенной 16-углеродной прямой цепью (H16:0) проявляли наиболее выраженный канцеростатический эффект (при 37 ° уровень жизнеспосоности составил 60,0%; при 42 ° 49,6% (WST-1)) по сравнению с таковым насыщенных и ненасыщенных HFAs, содержащих 12, 15 или 16 атомов углерода. анцеростатическая активность значительно возрастала при этилэтерификации насыщенных жирных кислот, таких как H16:0 (при 37 ° 42,3%; при 42 ° 11,2%, ibid) и H15:0 (при 37 ° 74,6%; при 42 ° 25,3% , ibid), в то время как производные ненасыщенных кислот были высокоэффективны только в комбинации с гипертермией. Увеличение периода инкубации клеток до 72 ч при той же концентрации веществ приводило к значительному увеличению их канцеростатического действия (этиловый эфир H16:0 1,3%; этиловый эфир H15:0 ethylesther 8,0%), подтвержденного данными окраски трипановым синим. рименение гипертермии также усиливало канцеростатическое действие соединений (1,2%; 2,1%, ibid). Результаты исследования методом SEM показали, что клетки EAT, инкубированные с этиловым эфиром H16:0, разруаются с нарушением клеточной структуры и исчезновением микроволокон. Выводы: в комбинации с гипертермией этиловый эфир H16:0 про ет высокую канцеростатическую активность in vitro, что говорит о возможности применения соединения в терапии опухолевых заболеваний.
- Published
- 2007
34. Promotive effects of hyperthermia on the inhibition of DNA synthesis in Ehrlich ascites tumor cells by eicosapentaenoic and docosahexaenoic acids
- Author
-
Tanaka, H., Kageyama, K., Kimura, M., Iwamoto, S.I., Ueno, Y., Asagi, K., Asada, R., and Miwa, N.
- Subjects
Original contributions - Abstract
Aim: To evaluate inhibitory effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on DNA synthesis in combination with hyperthermia in vitro. Methods: A suspension of Ehrlich ascites tumor cells (EAT) was mixed with DHA or EPA in a glass tube, heated at 37 °C, 40 °C, or 42 °C for 1 h in a water bath, and cultured at 37 °C for 19 or 96 h. DNA synthesis was assayed by monitoring of the incorporation of [3H]-thymidine into the acid-insoluble fraction. DHA or EPA incorporated into EAT cells was extracted and measured by thin-layer chromatography and gas-liquid chromatography. Results: The inhibition of DNA synthesis by EPA or DHA increased markedly upon the treatment at 42 °C and 40 °C compared to that at 37 °C. At 37 °C, inhibitory action of EPA was more potent than that of DHA at low concentrations (at 50 µM — DNA synthesis level: EPA, 63.1%; DHA, 87.9%), whereas inhibitory action of DHA was higher at 150 µM (16.7%, 4.4%, ibid.). The effect of DHA compared to EPA was more marked at 40 °C (29.0%, 19.2% at 100 µM) or 42 °C (19.7%, 10.6% at 100 µM). Evaluation of DNA synthesis rate in the cells treated for 1 h by EPA or DHA with the next culturing of EAT cells for 19 h resulted in the enhanced inhibitory activity of EPA even at concentrations as low as 50 µM at either 37 °C (0.5%, 11.3%) or 42 °C (0.6%, 4.5%), which in these conditions was higher than that of DHA. At the same time the rate of incorporation of EPA in EAT cells at 37 °C or 42 °C was lower than that of DHA. Conclusion: Administration of DHA or EPA in vitro significantly inhibit DNA synthesis, and such effect is enhanced by combination of PUFAs with hyperthermia. Цель: исследовать ингибирующее воздействие эйкозопентаеновой кислоты (EPA) и докозагексаеновой кислоты (DHA) на синтез ДНК в комбинации с гипертермией в модели in vitro. Методы: суспензию клеток асцитной карциномы Эрлиха (EAT) смешивали с DHA или EPA в стеклянной пробирке, инкубировали в течение 1 ч при 37 °C, 40 °C или 42 °C в водяной бане и культивировали при 37 °C 19 или 96 ч. Синтез ДНК оценивали по уровню включения [3 H]-тимидина. DHA или EPA, включившиеся в клетки EAT cells, экстрагировали, а их количество определяли методами тонкослойной и газожидкостной хроматографии. Результаты: степень ингибирования синтеза ДНК при действии EPA или DHA значительно возрастала при обработке клеток при 42 °C в сравнении с таковым при 37 °C. При 37 °C ингибирующее действие EPA было более выраженным, чем таковое DHA в низких концентрациях (при концентрации 50 μM — 63,1 против 87,9%), а DHA — более сильным при концентрации 150 μM (16,7 vs 4,4%). Эффект DHA в сравнении с EPA был более выраженным при 40 °C (29,0 vs 19,2% при концентрации 100 μM) или 42 °C (19,7 vs 10,6% при концентрации 100 μM). При обработке клеток EPA или DHA с последующим культивированием в течение 96 ч наблюдалось усиление ингибирующего воздействия EPA даже при концентрации 50 μM как при 37 °C (0,5 vs 11,3%), так и при 42 °C (0,6 vs 4,5%), что в таких условиях было значительнее, чем у DHA. В то же время степень включения EPA в клетки EAT при 37 °C или 42 °C была ниже, чем таковая DHA. Выводы: введение DHA или EPA in vitro значительно ингибирует синтез ДНК, и этот эффект усиливается на фоне комбинированного применения кислот и гипертермии.
- Published
- 2006
35. Decline in Liver Mitochondria Metabolic Function Is Restored by Hochuekkito Through Sirtuin 1 in Aged Mice With Malnutrition
- Author
-
Miwa Nahata, Naoki Fujitsuka, Hitomi Sekine, Chika Shimobori, Katsuya Ohbuchi, Seiichi Iizuka, Sachiko Mogami, Shunsuke Ohnishi, and Hiroshi Takeda
- Subjects
aging ,hochuekkito ,metabolomics ,mitochondria ,sirtuin1 ,Physiology ,QP1-981 - Abstract
Malnutrition impairs basic daily activities and leads to physical frailty, which is aggravated in the elderly compared with young adults. It is also well-known that the elderly are more vulnerable to metabolic stress. Therefore, in this study, using a food restricted (FR) mouse, we aimed to evaluate the effect of aging on locomotor activity and liver metabolic function. Further, we also investigated the involvement of hepatic mitochondria in liver metabolic function during aging, as well as the therapeutic benefit of the traditional Japanese medicine, hochuekkito (HET). Our findings indicated that following food restriction provided as 30% of ad libitum intake for 5 days, the locomotor activity was lower in 23–26-month-old (aged) mice than in 9-week-old (young) mice. Further, compared with young mice, aged mice exhibited significant decreases in the levels of metabolites related to the urea cycle, mitochondrial function, and anti-oxidative stress. The livers of the aged mice also showed a greater decrease in mitochondrial DNA copy number than young mice. Furthermore, the gene expression levels of sirtuin 1 (SIRT1) and mitochondrial biogenesis-related regulators were attenuated in aged mice. However, these changes were partially restored by HET treatment, which also improved locomotor activity, and combined treatment with alanine resulted in more significant effects in this regard. Therefore, our findings suggested that the decrease in locomotor activity in aged FR mice was associated with a decline in the metabolic function of hepatic mitochondria via decreased SIRT1 expression, which was restored by HET treatment. This implies that enhancing the metabolic function of liver mitochondria can contribute to alleviating energy deficiency in the elderly.
- Published
- 2022
- Full Text
- View/download PDF
36. DIALYSIS BONE DISEASE
- Author
-
Fusaro, M., primary, Giannini, S., additional, Miozzo, D., additional, Noale, M., additional, Tripepi, G., additional, Plebani, M., additional, Zaninotto, M., additional, Piccoli, A., additional, Vilei, M. T., additional, Cristofaro, R., additional, Gallieni, M., additional, Hamamoto, K., additional, Inaba, M., additional, Okuno, S., additional, Imanishi, Y., additional, Ishimura, E., additional, Yamakawa, T., additional, Shoji, S., additional, Rothe, H. M., additional, Eller, P., additional, Mayer, G., additional, Ketteler, M., additional, Kramar, R., additional, Shaheen, F., additional, Al Rukhaimi, M., additional, Alsahow, A., additional, Al-Ali, F., additional, Al Salmi, I., additional, Al Ghareeb, S., additional, Wang, M., additional, Bieber, B., additional, Robinson, B. M., additional, Pisoni, R. L., additional, Waniewski, J., additional, Debowska, M., additional, Wojcik-Zaluska, A., additional, Ksiazek, A., additional, Zaluska, W., additional, De Broe, M. E., additional, Wilson, R. J., additional, Copley, J. B., additional, Hiramtasu, R., additional, Ubara, Y., additional, Hoshino, J., additional, Takaichi, K., additional, Ghalli, F. G., additional, Ibakkanavar, R., additional, Chess, J., additional, Roberts, G., additional, Riley, S., additional, Oliveira, A. S. A., additional, Carvalho, C. J. B., additional, Oliveira, C. B. L., additional, Pessoa, C. T. B. C., additional, Leao, R. A. S., additional, Gueiros, J. E. B., additional, Gueiros, A. P. S., additional, Okano, K., additional, Tsuruta, Y., additional, Hibi, A., additional, Tsukada, M., additional, Miwa, N., additional, Kimata, N., additional, Tsuchiya, K., additional, Akiba, T., additional, Nitta, K., additional, Mizobuchi, M., additional, Ogata, H., additional, Hosaka, N., additional, Sanada, D., additional, Arai, N., additional, Koiwa, F., additional, Kinugasa, E., additional, Shibata, T., additional, Akizawa, T., additional, Delanaye, P., additional, Krzesinski, J.-M., additional, Warling, X., additional, Moonen, M., additional, Smelten, N., additional, Medart, L., additional, Pottel, H., additional, Cavalier, E., additional, Souberbielle, J.-C., additional, Gadisseur, R., additional, Dubois, B. E., additional, Matias, P., additional, Jorge, C., additional, Mendes, M., additional, Azevedo, A., additional, Navarro, D., additional, Ferreira, C., additional, Amaral, T., additional, Aires, I., additional, Gil, C., additional, Ferreira, A., additional, Kikuchi, H., additional, Shimada, H., additional, Karasawa, R., additional, Suzuki, M., additional, An, W. S., additional, Lee, S. M., additional, Oh, Y. J., additional, Son, Y. K., additional, De Paola, L., additional, Lombardi, G., additional, Panzino, M. T., additional, Lombardi, L., additional, Reichel, H., additional, Hahn, K.-M., additional, Kohnle, M., additional, Guggenberger, C., additional, Delanna, F., additional, Sasaki, N., additional, Tsunoda, M., additional, Ikee, R., additional, Hashimoto, N., additional, Sola, L., additional, Leyun, M. N., additional, Diaz, J. C., additional, Sehabiague, C., additional, Gonzalez, S., additional, Alallon, W., additional, Bourbeau, K., additional, Lajoie, C., additional, Macway, F., additional, Fujii, T., additional, Suzuki, S., additional, Shinozaki, M., additional, Tanaka, H., additional, Klingele, M., additional, Seiler, S., additional, Poppleton, A., additional, Lepper, P., additional, Fliser, D., additional, Seidel, R., additional, Lun, L., additional, Liu, D., additional, Li, X., additional, Wei, X., additional, Miao, J., additional, Gao, Z., additional, Hu, R., additional, Gros, B., additional, Galan, A., additional, Gonzalez-Parra, E., additional, Herrero, J. A., additional, Echave, M., additional, Vegter, S., additional, Tolley, K., additional, Oyaguez, I., additional, Gutzwiller, F. S., additional, Braunhofer, P. G., additional, Szucs, T. D., additional, Schwenkglenks, M., additional, Yilmaz, V. T., additional, Ozdem, S., additional, Donmez, L., additional, Kocak, H., additional, Dinckan, A., additional, Cetinkaya, R., additional, Suleymanlar, G., additional, and Ersoy, F. F., additional
- Published
- 2014
- Full Text
- View/download PDF
37. Late-gadolinium enhancement in a subject with normal left ventricular function
- Author
-
Ikuo Misumi, MD, Koji Sato, MD, Miwa Nagano, MD, Joji Urata, MD, Hiroki Usuku, MD, Koichi Kaikita, MD, and Kenichi Tsujita, MD
- Subjects
Mid-layer enhancement in late-gadolinium enhancement ,Normal left ventricular function ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
A 27-year-old man visited our hospital after experiencing palpitations. His 12-lead electrocardiogram and chest radiograph were unremarkable. Blood test results showed normal plasma brain natriuretic peptide level (
- Published
- 2020
- Full Text
- View/download PDF
38. Regulation of mammalian phospholipase D2: interaction with and stimulation by G(M2) activator
- Author
-
Sarkar, S, Miwa, N, Kominami, H, Igarashi, N, Hayashi, S, Okada, T, Jahangeer, S, and Nakamura, S
- Subjects
G(M2) Activator Protein ,Molecular Sequence Data ,Proteins ,Recombinant Proteins ,Cell Line ,Enzyme Activation ,Isoenzymes ,Phospholipase D ,Animals ,Humans ,Tetradecanoylphorbol Acetate ,Amino Acid Sequence ,Sequence Alignment ,Research Article - Abstract
We have previously reported that a heat-stable activator for ganglioside metabolism, G(M2) activator, potently stimulates ADP-ribosylation factor (ARF)-dependent phospholipase D (PLD) activity (presumably PLD1) in an in vitro system [Nakamura, Akisue, Jinnai, Hitomi, Sarkar, Miwa, Okada, Yoshida, Kuroda, Kikkawa and Nishizuka (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 12249-12253]. However, little is known about the regulation of PLD2. In the present studies we have investigated the regulation of PLD2 by G(M2) activator and various other regulators including ARF. PLD2 was potently stimulated in vitro by G(M2) activator in a time- and dose-dependent manner. Neither ARF nor protein kinase C caused any significant changes in PLD2 activity. Importantly, PLD2 responsiveness to ARF was greatly enhanced by G(M2) activator, suggesting a possible role for G(M2) activator as a coupling factor. G(M2) activator was also demonstrated to physically associate with PLD2 in a stoichiometric manner. Further, PMA stimulation of COS-7 cells overexpressing both G(M2) activator and PLD2 resulted in a marked increase in the association of the two molecules. Interestingly, ARF association with PLD2 was greatly increased by G(M2) activator. Moreover, G(M2) activator enhanced PMA-induced PLD activity in a synergistic manner with ARF in streptolysin-O-permeabilized, cytosol-depleted HL-60 cells, suggesting that G(M2) activator may regulate PLD in a concerted manner with other factors, including ARF, inside the cells.
- Published
- 2001
39. Identification of AF17 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis
- Author
-
Ym, Lin, Ono K, Satoh S, Ishiguro H, Fujita M, Miwa N, Toshihiro Tanaka, Tsunoda T, Kc, Yang, Nakamura Y, and Furukawa Y
- Subjects
Transcriptional Activation ,Transcription, Genetic ,Lymphoid Enhancer-Binding Factor 1 ,Cell Cycle ,3T3 Cells ,Transfection ,Neoplasm Proteins ,DNA-Binding Proteins ,Cytoskeletal Proteins ,Mice ,COS Cells ,Chlorocebus aethiops ,Trans-Activators ,Tumor Cells, Cultured ,Animals ,Humans ,Colorectal Neoplasms ,Cell Division ,beta Catenin ,Oligonucleotide Array Sequence Analysis ,Signal Transduction ,Transcription Factors - Abstract
To elucidate the molecular mechanism of colorectal carcinogenesis, we have been attempting to isolate genes involved in the beta-catenin/T-cell factor pathway. In the experiments reported here, analysis by cDNA microarray indicated that AF17, a fusion partner of the MLL gene in acute leukemias with t(11;17)(q23;q21), was transactivated according to accumulation of beta-catenin. Expression of AF17 was significantly enhanced in 8 of the 12 colorectal cancer tissues examined. Introduction of a plasmid designed to express AF17 stimulated growth of NIH3T3 cells, and fluorescence-activated cell sorter analysis indicated that the AF17 regulation of cell-cycle progression was occurring mainly at the G(2)-M transition. Our results suggest that the AF17 gene product is likely to be involved in the beta-catenin-T-cell factor/lymphoid enhancer factor signaling pathway and to function as a growth-promoting, oncogenic protein. These findings should aid development of new strategies for diagnosis, treatment, and prevention of colon cancers and acute leukemias by clarifying the pathogenesis of these conditions.
- Published
- 2001
40. Mutations in BMP4 Are Associated with Subepithelial, Microform, and Overt Cleft Lip
- Author
-
Suzuki, S, Marazita, ML, Cooper, ME, Miwa, N, Hing, A, Jugessur, A, Natsume, N, Shimozato, K, Ohbayashi, N, Suzuki, Y, Niimi, T, Minami, K, Yamamoto, M, Altannamar, TJ, Erkhembaatar, T, Furukawa, H, Daack-Hirsch, S, L'Heureux, J, Brandon, CA, Weinberg, SM, Neiswanger, K, Deleyiannis, FWB, de Salamanca, JE, Vieira, AR, Lidral, AC, Martin, JF, Murray, JC, Suzuki, S, Marazita, ML, Cooper, ME, Miwa, N, Hing, A, Jugessur, A, Natsume, N, Shimozato, K, Ohbayashi, N, Suzuki, Y, Niimi, T, Minami, K, Yamamoto, M, Altannamar, TJ, Erkhembaatar, T, Furukawa, H, Daack-Hirsch, S, L'Heureux, J, Brandon, CA, Weinberg, SM, Neiswanger, K, Deleyiannis, FWB, de Salamanca, JE, Vieira, AR, Lidral, AC, Martin, JF, and Murray, JC
- Abstract
Cleft lip with or without cleft palate (CL/P) is a complex trait with evidence that the clinical spectrum includes both microform and subepithelial lip defects. We identified missense and nonsense mutations in the BMP4 gene in 1 of 30 cases of microform clefts, 2 of 87 cases with subepithelial defects in the orbicularis oris muscle (OOM), 5 of 968 cases of overt CL/P, and 0 of 529 controls. These results provide confirmation that microforms and subepithelial OOM defects are part of the spectrum of CL/P and should be considered during clinical evaluation of families with clefts. Furthermore, we suggest a role for BMP4 in wound healing. © 2009 The American Society of Human Genetics.
- Published
- 2009
41. CKD-MBD II
- Author
-
Fujii, T., primary, Suzuki, S., additional, Shinozaki, M., additional, Tanaka, H., additional, Bell, S., additional, Cooper, S., additional, Lomonte, C., additional, Libutti, P., additional, Chimienti, D., additional, Casucci, F., additional, Bruno, A., additional, Antonelli, M., additional, Lisi, P., additional, Cocola, L., additional, Basile, C., additional, Negri, A., additional, Del Valle, E., additional, Zanchetta, M., additional, Zanchetta, J., additional, Di Vico, M. C., additional, Ferraresi, M., additional, Pia, A., additional, Aroasio, E., additional, Gonella, S., additional, Mongilardi, E., additional, Clari, R., additional, Moro, I., additional, Piccoli, G. B., additional, Gonzalez-Parra, E., additional, Rodriguez-Osorio, L., additional, Ortiz-Arduan, A., additional, de la Piedra, C., additional, Egido, J., additional, Perez Gomez, M. V., additional, Tabikh, A. A., additional, Afsar, B., additional, Kirkpantur, A., additional, Imanishi, Y., additional, Yamagata, M., additional, Nagata, Y., additional, Ohara, M., additional, Michigami, T., additional, Yukimura, T., additional, Inaba, M., additional, Bieber, B., additional, Robinson, B., additional, Mariani, L., additional, Jacobson, S., additional, Frimat, L., additional, Bommer, J., additional, Pisoni, R., additional, Tentori, F., additional, Ciceri, P., additional, Elli, F., additional, Brancaccio, D., additional, Cozzolino, M., additional, Adamczak, M., additional, Wiecek, A., additional, Kuczera, P., additional, Sezer, S., additional, Bal, Z., additional, Tutal, E., additional, Kal, O., additional, Yavuz, D., additional, Y ld r m, I., additional, Sayin, B., additional, Ozelsancak, R., additional, Ozkurt, S., additional, Turk, S., additional, Ozdemir, N., additional, Lehmann, R., additional, Roesel, M., additional, Fritz, P., additional, Braun, N., additional, Ulmer, C., additional, Steurer, W., additional, Dagmar, B., additional, Ott, G., additional, Dippon, J., additional, Alscher, D., additional, Kimmel, M., additional, Latus, J., additional, Turkvatan, A., additional, Balci, M., additional, Mandiroglu, S., additional, Seloglu, B., additional, Alkis, M., additional, Serin, M., additional, Calik, Y., additional, Erkula, S., additional, Gorboz, H., additional, Mandiroglu, F., additional, Lindley, E., additional, Cruz Casal, M., additional, Rogers, S., additional, Pancirova, J., additional, Kernc, J., additional, Copley, J. B., additional, Fouque, D., additional, Kiss, I., additional, Kiss, Z., additional, Szabo, A., additional, Szegedi, J., additional, Balla, J., additional, Ladanyi, E., additional, Csiky, B., additional, orkossy, O., additional, Torok, M., additional, Turi, S., additional, Ambrus, C., additional, Deak, G., additional, Tisler, A., additional, Kulcsar, I., additional, K d r, V., additional, Altuntas, A., additional, Akp nar, A., additional, Orhan, H., additional, Sezer, M., additional, Filiopoulos, V., additional, Manolios, N., additional, Arvanitis, D., additional, Pani, I., additional, Panagiotopoulos, K., additional, Vlassopoulos, D., additional, Rodriguez-Ortiz, M. E., additional, Canalejo, A., additional, Herencia, C., additional, Martinez-Moreno, J. M., additional, Peralta-Ramirez, A., additional, Perez-Martinez, P., additional, Navarro-Gonzalez, J. F., additional, Rodriguez, M., additional, Peter, M., additional, Gundlach, K., additional, Steppan, S., additional, Passlick-Deetjen, J., additional, Munoz-Castaneda, J. R., additional, Almaden, Y., additional, Rodriguez-Ortiz, M., additional, Martinez-Moreno, J., additional, Lopez, I., additional, Aguilera-Tejero, E., additional, Hanafusa, N., additional, Masakane, I., additional, Ito, S., additional, Nakai, S., additional, Maeda, K., additional, Suzuki, H., additional, Tsunoda, M., additional, Ikee, R., additional, Sasaki, N., additional, Sato, M., additional, Hashimoto, N., additional, Wang, M.-H., additional, Hung, K.-Y., additional, Chiang, C.-K., additional, Huang, J.-W., additional, Lu, K.-C., additional, Lang, C.-L., additional, Okano, K., additional, Yamashita, T., additional, Tsuruta, Y., additional, Hibi, A., additional, Miwa, N., additional, Kimata, N., additional, Tsuchiya, K., additional, Nitta, K., additional, Akiba, T., additional, Harb, L., additional, Komaba, H., additional, Kakuta, T., additional, Suga, T., additional, Fukagawa, M., additional, Kikuchi, H., additional, Shimada, H., additional, Karasawa, R., additional, Suzuki, M., additional, Zhelyazkova-Savova, M., additional, Gerova, D., additional, Paskalev, D., additional, Ikonomov, V., additional, Zortcheva, R., additional, Galunska, B., additional, Jean, G., additional, Deleaval, P., additional, Hurot, J.-M., additional, Lorriaux, C., additional, Mayor, B., additional, Chazot, C., additional, Vannucchi, H., additional, Vannucchi, M. T., additional, Martins, J. C., additional, Merino, J. L., additional, Teruel, J. L., additional, Fernandez-Lucas, M., additional, Villafruela, J. J., additional, Bueno, B., additional, Gomis, A., additional, Paraiso, V., additional, Quereda, C., additional, Ibrahim, F. H., additional, Fadhlina, N. Z., additional, Ng, E. K., additional, Thong, K. M., additional, Goh, B. L., additional, Sulaiman, D. M., additional, Fatimah, D. A. N., additional, Evi, D. O., additional, Siti, S. R., additional, Wilson, R. J., additional, Keith, M., additional, Gros, B., additional, Galan, A., additional, Herrero, J. A., additional, Oyaguez, I., additional, Casado, M. A., additional, Lucisano, S., additional, Coppolino, G., additional, Villari, A., additional, Cernaro, V., additional, Lupica, R., additional, Trimboli, D., additional, Aloisi, C., additional, and Buemi, M., additional
- Published
- 2013
- Full Text
- View/download PDF
42. A Multilateration-based Localization Scheme for Adhoc Wireless Positioning Networks Used in Information-oriented Construction
- Author
-
Miwa, N., primary, Tagashira, S., additional, Matsuda, H., additional, Tsutsui, T., additional, Arakawa, Y., additional, and Fukuda, A., additional
- Published
- 2013
- Full Text
- View/download PDF
43. Appropriate Immediate Dentin Sealing to Improve the Bonding of CAD/CAM Ceramic Crown Restorations
- Author
-
Miwa Nakazawa, Masahiko Maeno, Mei Komoto, and Yoichiro Nara
- Subjects
immediate dentin sealing ,bonding performance ,CAD/CAM restoration ,ceramic crown ,cyclic loading ,micro-tensile bond strength ,Organic chemistry ,QD241-441 - Abstract
This study aimed to use quantitative and qualitative evaluations based on micro-tensile bond strength (μTBS) to clarify the appropriate immediate dentin sealing (IDS) approach for improving the bonding of CAD/CAM ceramic crown restorations. Forty-eight extracted human molars were prepared to obtain standardized abutment specimens and divided into three groups: no IDS (group C: control), IDS performed by a single application of an all-in-one adhesive system (group A), and IDS performed by the combined application of an adhesive system and a flowable resin composite (group F). All specimens were restored with a ceramic crown fabricated by a chair-side CAD/CAM system and were divided into no-stress and stressed groups. After cyclic loading (78.5 N; total, 3 × 105 cycles; 90 cycles/min) on the specimens in the stressed group, all specimens were sectioned. The μTBS values for the occlusal and mesioaxial walls were measured (n = 16) and analyzed statistically. The quantitative bonding performance of groups A and F were superior to that of group C, regardless of the cyclic loading and abutment wall conditions. Group F showed the maximum bond strength and the highest bond durability in the qualitative bonding performance even under the cyclic loading condition simulating clinical mastication.
- Published
- 2022
- Full Text
- View/download PDF
44. Measurement of Skin Thickness Using Ultrasonography to Test the Usefulness of Elastic Compression Stockings for Leg Edema in Pregnant Women
- Author
-
Airi Banba, Masafumi Koshiyama, Yumiko Watanabe, Koji Makino, Eri Ikuta, Nami Yanagisawa, Ayumi Ono, Miwa Nakagawa, Keiko Seki, Shin-ichi Sakamoto, Yoko Hara, and Akira Nakajima
- Subjects
skin thickness ,ultrasonography ,leg edema ,pregnancy ,elastic compression stockings ,Medicine - Abstract
Background: One of the most common treatments for leg edema during pregnancy is the use of compression stockings. The purpose of this study was to evaluate the objective effectiveness in pregnant women, by measuring the changes of skin thickness using ultrasonography. Methods: Pregnant women were diagnosed with leg edema using the pitting edema method at 36 weeks of gestation. Twenty-four pregnant women (48 legs) with leg edema spent time without wearing elastic stockings at 36–37 weeks of gestation. Then, they wore elastic stockings for one week at 37–38 weeks of gestation. We measured the grade of edema (from 0 to 3) and the skin thickness of the lower leg by portable ultrasonography at 36, 37, and 38 weeks of gestation (a before-and-after study). Results: In 24 pregnant women, thigh edema was not detected in any of the 48 legs before or after the use of elastic stockings. All 48 legs in 24 pregnant women had physiological lower leg edema, but not thigh edema. The average grade of pitting edema in each lower leg significantly decreased after using the stockings (36 weeks, 1.77 ± 0.85; 37 weeks, 1.79 ± 0.77; 38 weeks, 1.04 ± 0.74, p < 0.0001). In addition, the skin thickness of the lower legs was significantly decreased after the use of elastic stockings (36 weeks, 7.47 ± 2.45 mm; 37 weeks, 7.93 ± 2.83 mm; 38 weeks, 7.15 ± 2.35 mm, p < 0.0001). Conclusions: The wearing of elastic compression stockings on the lower legs is objectively effective for improving leg edema in pregnant women.
- Published
- 2022
- Full Text
- View/download PDF
45. Earable Ω (OMEGA): A Novel Clenching Interface Using Ear Canal Sensing for Human Metacarpophalangeal Joint Control by Functional Electrical Stimulation
- Author
-
Kazuhiro Matsui, Yuya Suzuki, Keita Atsuumi, Miwa Nagai, Shotaro Ohno, Hiroaki Hirai, Atsushi Nishikawa, and Kazuhiro Taniguchi
- Subjects
functional electrical stimulation ,ear canal sensor ,clenching ,spinal cord injury ,finger ,Chemical technology ,TP1-1185 - Abstract
(1) Background: A mouth-free interface is required for functional electrical stimulation (FES) in people with spinal cord injuries. We developed a novel system for clenching the human metacarpophalangeal (MP) joint using an earphone-type ear canal movement sensor. Experiments to control joint angle and joint stiffness were performed using the developed system. (2) Methods: The proposed FES used an equilibrium point control signal and stiffness control signal: electrical agonist–antagonist ratio and electrical agonist–antagonist sum. An angle sensor was used to acquire the joint angle, and system identification was utilized to measure joint stiffness using the external force of a robot arm. Each experiment included six and five subjects, respectively. (3) Results: While the joint angle could be controlled well by clenching with some hysteresis and delay in three subjects, it could not be controlled relatively well after hyperextension in the other subjects, which revealed a calibration problem and a change in the characteristics of the human MP joint caused by hyperextension. The joint stiffness increased with the clenching amplitude in five subjects. In addition, the results indicated that viscosity can be controlled. (4) Conclusions: The developed system can control joint angle and stiffness. In future research, we will develop a method to show that this system can control the equilibrium point and stiffness simultaneously.
- Published
- 2022
- Full Text
- View/download PDF
46. Cell signalling / Pathophysiology
- Author
-
Cerini, C., primary, Gondouin, B., additional, Dou, L., additional, Duval-Sabatier, A., additional, Brunet, P., additional, Dignat- George, F., additional, Burtey, S., additional, Okano, K., additional, Iwasaki, T., additional, Jinnai, H., additional, Hibi, A., additional, Miwa, N., additional, Kimata, N., additional, Nitta, K., additional, Akiba, T., additional, Dolley-Hitze, T., additional, Verhoest, G., additional, Jouan, F., additional, Arlot-Bonnemains, Y., additional, Lavenu, A., additional, Belaud-Rotureau, M.-A., additional, Rioux-Leclercq, N., additional, Vigneau, C., additional, Cox, S. N., additional, Sallustio, F., additional, Serino, G., additional, Loverre, A., additional, Pesce, F., additional, Gigante, M., additional, Zaza, G., additional, Stifanelli, P., additional, Ancona, N., additional, Schena, F. P., additional, Marc, P., additional, Jacques, T., additional, Green, J. M., additional, Mortensen, R. B., additional, Verma, R., additional, Leu, K., additional, Schatz, P. J., additional, Wojchowski, D. M., additional, Ihoriya, C., additional, Satoh, M., additional, Sasaki, T., additional, Kashihara, N., additional, Jung, Y. J., additional, Kang, K. P., additional, Lee, A. S., additional, Lee, J. E., additional, Lee, S., additional, Park, S. K., additional, Kim, W., additional, Florian, T., additional, Tepel, M., additional, Ying, L., additional, Katharina, K., additional, Nora, F., additional, Antje, W., additional, Alexandra, S., additional, Chiu, Y.-T., additional, Wu, M.-J., additional, Liu, Z.-H., additional, Liang, Y., additional, Zheng, C.-X., additional, Chen, Z.-H., additional, Zeng, C.-H., additional, Ranzinger, J., additional, Rustom, A., additional, Kihm, L., additional, Heide, D., additional, Scheurich, P., additional, Zeier, M., additional, Schwenger, V., additional, Liu, J., additional, Zhong, F., additional, Xu, L., additional, Zhou, Q., additional, Hao, X., additional, Wang, W., additional, Chen, N., additional, Liu, X., additional, Lu, Y., additional, Guo, S., additional, Lin, D., additional, Vilasi, A., additional, Deplano, S., additional, Cutillas, P., additional, Unwin, R., additional, Tam, F. W. K., additional, Medrano-Andres, D., additional, Lopez-Martinez, V., additional, Martinez-Miguel, P., additional, Cano, J. L., additional, Arribas, I., additional, Rodiguez-Puyol, M., additional, Lopez-Ongil, S., additional, Kadoya, H., additional, Nagasu, H., additional, Lindeberg, E., additional, Grundstrom, G., additional, Alexandra, M., additional, Ghosh, C. C., additional, David, S., additional, Mukherjee, A., additional, John, S. G., additional, Mcintyre, C. W., additional, Haller, H., additional, Parikh, S. M., additional, Troyano, N., additional, Del Nogal, M., additional, Olmos, G., additional, Mora, I., additional, DE Frutos, S., additional, Rodriguez-Puyol, M., additional, Ruiz, M. P., additional, Rothe, H., additional, Shapiro, W., additional, Ketteler, M., additional, Ramakrishnan, S. K., additional, Loupy, A., additional, Houillier, P., additional, Guilhermino Pereira, L., additional, Boim, M., additional, Aragao, D., additional, Casarini, D., additional, Jin, Y., additional, Moon, J.-Y., additional, Kim, Y.-G., additional, Lee, S.-H., additional, Lee, T.-W., additional, Ihm, C.-G., additional, Kim, E.-Y., additional, Lee, H.-J., additional, Wi, J.-G., additional, Jeong, K.-H., additional, Ruan, X. Z., additional, LI, L.-C., additional, Varghese, Z., additional, Chen, J.-B., additional, Lee, C.-T., additional, Moorhead, J., additional, Cerini, C., additional, Poitevin, S., additional, Dignat-George, F., additional, Stephane, B., additional, Bonanni, A., additional, Verzola, D., additional, Maggi, D., additional, Brunori, G., additional, Sofia, A., additional, Mannucci, I., additional, Maffioli, S., additional, Salani, B., additional, D'amato, E., additional, Saffioti, S., additional, Laudon, A., additional, Cordera, R., additional, Garibotto, G., additional, Maquigussa, E., additional, and Arnoni, C., additional
- Published
- 2012
- Full Text
- View/download PDF
47. Cell signalling
- Author
-
Negoro, H., primary, Kobayashi, H., additional, Teng, B., additional, Schafer, I., additional, Starker, G., additional, Miller, E., additional, Mao, Y., additional, Park, J.-K., additional, Haller, H., additional, Schiffer, M., additional, Lu, Y., additional, Zhong, F., additional, Zhou, Q., additional, Hao, X., additional, Li, C., additional, Guo, S., additional, Wang, W., additional, Chen, N., additional, Okano, K., additional, Jinnai, H., additional, Iwasaki, T., additional, Miwa, N., additional, Kimata, N., additional, Akiba, T., additional, Nitta, K., additional, Chen, C.-A., additional, Cheng, Y.-C., additional, Hwang, J.-C., additional, Chang, J.-M. C., additional, Guh, J.-Y., additional, Chen, H.-C., additional, Garcia-Sanchez, O., additional, Lopez-Novoa, J. M., additional, Lopez-Hernandez, F. J., additional, Hirai, Y., additional, Iyoda, M., additional, Shibata, T., additional, Kuno, Y., additional, Akizawa, T., additional, Shimizu, H., additional, Bolati, D., additional, Niwa, T., additional, Kim, Y. K., additional, Nam, S. A., additional, Kim, W.-Y., additional, Park, S. H., additional, Song, H. C., additional, Choi, E. J., additional, Kim, J., additional, Sirolli, V., additional, Giardinelli, A., additional, Morabito, C., additional, Di Cesare, M., additional, Di Pietro, N., additional, Di Liberato, L., additional, Amoroso, L., additional, Mariggio, M. A., additional, Formoso, G., additional, Pandolfi, A., additional, Bonomini, M., additional, Shalhoub, V., additional, Shatzen, E., additional, Ward, S., additional, Damore, M., additional, Boedigheimer, M., additional, Campbell, M., additional, Pan, Z., additional, Davis, J., additional, Henley, C., additional, Richards, W., additional, Yoshida, T., additional, Yamashita, M., additional, Hayashi, M., additional, Bodor, C., additional, Nemeth, A., additional, Berzsenyi, V., additional, Vegh, B., additional, Sebe, A., additional, Rosivall, L., additional, Koken, T., additional, Hunkerler, Z., additional, Kahraman, A., additional, Verzola, D., additional, Villaggio, B., additional, Tosetti, F., additional, Cappuccino, L., additional, Gianiorio, F., additional, Simonato, A., additional, Parodi, E., additional, Garibotto, G., additional, Chai, Y., additional, Liu, J., additional, Sun, B., additional, Zhao, X., additional, Qian, J., additional, and Xing, C., additional
- Published
- 2011
- Full Text
- View/download PDF
48. ChemInform Abstract: Studies on Pyrazines. Part 27. A New Deoxidative Nucleophilic Substitution of Pyrazine N-Oxides; Synthesis of Azidopyrazines with Trimethylsilyl Azide.
- Author
-
SATO, N., primary, MIWA, N., additional, and HIROKAWA, N., additional
- Published
- 2010
- Full Text
- View/download PDF
49. ChemInform Abstract: Studies on Pyrazines. Part 28. Deoxydative Acetoxylation of Pyrazine N- Oxides.
- Author
-
SATO, N., primary, MIWA, N., additional, SUZUKI, H., additional, and SAKAKIBARA, T., additional
- Published
- 2010
- Full Text
- View/download PDF
50. Effect of deamidation by protein-glutaminase on physicochemical and functional properties of skim milk
- Author
-
Miwa, N., primary, Yokoyama, K., additional, Wakabayashi, H., additional, and Nio, N., additional
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.